Bioactivation of aflatoxin B1 by turkey liver microsomes: Responsible cytochrome P450 enzymes

British Poultry Science

Volumn 51, Issue 6, 2010, Pages 828-837

  Diaz, G J ^a   Murcia, H W ^a   Cepeda, S M ^a  

^a UNIVERSIDAD NACIONAL DE COLOMBIA   (Colombia)

Author keywords

[No Author keywords available]

Indexed keywords

AFLATOXIN B1; ALPHA NAPHTHOFLAVONE; ALPHA-NAPHTHOFLAVONE; BENZOFLAVONE DERIVATIVE; CYTOCHROME P450; ENZYME INHIBITOR; METHOXSALEN;

ANIMAL; ARTICLE; ENZYMOLOGY; FEMALE; IMMUNOBLOTTING; KINETICS; LIVER; LIVER MICROSOME; MALE; METABOLISM; TURKEY (BIRD);

AFLATOXIN B1; ANIMALS; BENZOFLAVONES; CYTOCHROME P-450 ENZYME SYSTEM; ENZYME INHIBITORS; FEMALE; IMMUNOBLOTTING; KINETICS; LIVER; MALE; METHOXSALEN; MICROSOMES, LIVER; TURKEYS;

AVES;

EID: 78650235846     PISSN: 00071668     EISSN: 14661799     Source Type: Journal    
DOI: 10.1080/00071668.2010.528752     Document Type: Article

References (39)

1. Barraud, L., Guerret, S., Chevallier, M., Borel, C., Jamard, C., Trepo, C., Wild, C.P. & Cova, L. (1999) Enhanced duck hepatitis B virus gene expression following aflatoxin B1 exposure. Hepatology, 29: 1317-1323.
2. Bisswanger, H. (2008) Enzyme kinetics. Principles and methods, 2nd edn (Weinheim, Germany, Wiley-VCH Verlag GmbH & Co. KGaA).
3. Blanchard, J. (1981) Evaluation of the relative efficacy of various techniques for deproteinizing plasma samples prior to high-performance liquid chromatography analysis. Journal of Chromatography, 226: 455-460.
4. Bünger, J., Westphal, G., Mönnich, A., Hinnendahl, B., Hallier, E. & Müller, M. (2004) Cytotoxicity of occupa-tionally and environmentally relevant mycotoxins. Toxicology, 202: 199-211.
5. Cervino, C., Knopp, D., Weller, M.G. & Niessner, R. (2007) Novel aflatoxin derivatives and protein conjugates. Molecules, 12: 641-653.
6. Diaz, G.J., Cortés, A. & Botero, L. (2009) Evaluation of the ability of a feed additive to ameliorate the adverse effects of aflatoxins in turkey poults. British Poultry Science, 50: 240-250.
7. Do, J.H. & Choi, D. (2007) Aflatoxins: detection, toxicity, and biosynthesis. Biotechnology and Bioprocess Engineering, 12: 585-593.
8. Doi, A.M., Patterson, P.E. & Gallagher, E.P. (2002) Variability in aflatoxin B1-macromolecular binding and relationship to biotransformation enzyme expression in human prenatal and adult liver. Toxicology and Applied Pharmacology, 181: 48-59.
9. Eagling, V.A., Tjia, J.F. & Back, D.J. (1998) Differential selectivity of cytochrome P450 inhibitors against probe substrates in human and rat liver microsomes. British Journal of Clinical Pharmacology, 45: 107-114.
10. Eaton, D.L. & Gallagher, E.P. (1994) Mechanisms of aflatoxin carcinogenesis. Annual Review of Pharmacology and Toxicology, 34: 135-172.
11. Fink, D.W. & Koehler, W.R. (1970) pH effects on fluorescence of umbelliferone. Analytical Chemistry, 42: 990-993.
12. Gallagher, E., Kunze, K.L., Stapleton, P.L. & Eaton, D.L. (1996) The kinetics of aflatoxin B1 oxidation by human cDNA-expressed and human liver microsomal cyto-chromes P450 1A2 and 3A4. Toxicology and Applied Pharmacology, 141: 595-606.
13. Granvil, C.P., Krausz, K.W., Gelboin, H.V., Idle, J.R. & Gonzales, F.J. (2002) 4-Hydroxylation of debrisoquine by human CYP1A1 and its inhibition by quinidine and quinine. Journal of Pharmacology and Experimental Therapeutics, 301: 1025-1032.
14. Guengerich, F.P., Johnson, W.W., Ueng, Y.F., Yamazaki, H. & Shimada, T. (1996) Involvement of cytochrome P450, glutathione S-transferase and epoxide hydrolase in the metabolism of aflatoxin B1 and relevance to risk of human liver cancer. Enviromental Health Perspectives, 104: 557-562.
15. Guengerich, F.P., Johnson, W.W., Shimada, T., Ueng, Y.F., yamazaki, H. & Langouët, S. (1998) Activation and detoxication of aflatoxin B1. Mutation Research, 402: 121-128.
16. Halpert, J.R., Guengerich, F.P., Bend, J.R. & Correia, M.A. (1994) Selective inhibitors of cytochromes P450. Toxicology and Applied Pharmacology, 125: 163-175.
17. Kadian, S.K., Monga, D.P. & Goel, M.C. (1988) Effect of aflatoxin B1 on the delayed hypersensitivity and phagocy-tic activity of reticuloendotelial system in chickens. Mycopathologia, 104: 33-36.
18. Kakkar, T., Boxenbaum, H. & Mayersohn, M. (1999) Estimation of Ki in a competitive enzyme-inhibition model: comparisons among three methods of data analysis. Drug Metabolism and Disposition, 27: 756-762.
19. Klaassen, C.D. (Ed). 2008. Casarett and Doull's Toxicology -The Basic Science of Poisons (New York, McGraw Hill Medical).
20. Klein, P.J., Buckner, R., Kelly, J. & Coulombe, R.A. (2000) Biochemical basis for the extreme sensivity of turkeys to aflatoxin B1. Toxicology and Applied Pharmacology, 165: 45-52.
21. Kunze, K.L. & Trager, W.F. (1993) Isoform-selective mechanism-based inhibition of human cytochrome P450 1A2 by furafylline. Chemical Research in Toxicology, 6: 649-656.
22. Laemmli, U.K. (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature, 227: 680-685.
23. Leclercq, I., Desager, J.P., Vandenplas, C. & Horsmans, Y. (1996) Fast determination of low level cytochrome P-450 1A1 activity by high-performance liquid chromatography with fluorescence or visible absorbance detection. Journal of Chromatography B, 681: 227-232.
24. Lozano, M.C. & Diaz, G.J. (2006) Microsomal and cytosolic biotransformation of aflatoxin B1 in four poultry species. British Poultry Science, 47: 734-741.
25. Marangoni, A.G. (2003) Enzyme kinetics. A modern approach (Hoboken, New Jersey, John Wiley & Sons, Inc.).
26. McLean, M. & Dutton, M.F. (1995) Cellular interactions and metabolism of aflatoxin: an update. Pharmacology and Therapeutics, 65: 163-192.
27. Nelson, D.R., Koymans, L., Kamataki, T., Stegeman, J.J., feyereisen, R., Waxman, D.J., Waterman, M.R., Gotoh, O., Coon, M.J., Estabrook, R.W., Gunsalus, I.C. & Nebert, D.W. (1996) P450 superfamily: update on new sequences, gene mapping, accession numbers and nomenclature. Pharmacogenetics, 6: 1-42.
28. Oliveira, C.A., Rosmaninho, J.F., Butkeraitis, P., Corréa, B., Reis, T.A., Guerra, J.L., Albuquerque, R. & Moro, M.E. (2002) Effect of low levels of dietary aflatoxin B1 on laying japanese quail. Poultry Science, 81: 976-980.
29. Omiencinski, C.J., Remmel, R.P. & Hosagrahara, V.P. (1999) Concise review of the cytochrome P450s and their role in toxicology. Toxicological Sciences, 48: 151-156.
30. Pereira, V.A., Auler, J.O. Jr, Carmona, M.J., Mateus, F.H., Lanchote, V.L., Breimer, D.D. & Santos, S.R. (2000) A micromethod for quantitation of debrisoquine and 4-hydroxydebrisoquine in urine by liquid chromatography. Brazilian Journal of Medical and Biological Research, 33: 509-514.
31. Redinbaugh, M.G. & Turley, R.B. (1986) Adaptation of the bicinchoninic acid protein assay for the use with microtiter plates and sucrose gradient fractions. Analytical Biochemistry, 153: 267-271.
32. Sargeant, K., Sheridan, A., O'Kelly, J. & Carnagham, R.B.A. (1961) Toxicity associated with certain samples of groundnuts. Nature, 192: 1096-1097.
33. SAS Institute Inc. (2008). SAS/STAT 9-2 User's Guide (Cary, N.C., USA, SAS Institute, Inc.).
34. Sesardic, D., Boobis, A.R., Murray, B.P., Murray, S., Segura, J., De la Torre, R. & Davies, D.S. (1990) Furafylline is a potent and selective inhibitor of cytochrome P450IA2 in man. British Journal of Clinical Pharmacology, 29: 651-663.
35. Shim, S.C., Pae, A.N. & Lee, Y.J. (1988) Mechanistic studies on the photochemical degradation of nifedipine. Bulletin of the Korean Chemical Society, 9: 271-332.
36. Verma, R.J. (2004) Aflatoxin causes DNA damage. Intenational Journal of Human Genetics, 4: 231-236.
37. Walker, C.H. (1998) Avian forms of cytochrome P450. Comparative Biochemistry and Physiology Part C, 121: 65-72.
38. Wild, C.P. & Turner, P.C. (2002) The toxicology of aflatoxins as a basis for public health decisions. Mutagenesis, 17: 471-481.
39. Yamano, S., Tatsuno, J. & Gonzalez, F.J. (1990) The CYP2A3 gene product catalyzes coumarin 7-hydro-xylation in human liver microsomes. Biochemistry, 29: 1322-1329.